loading...| Preferred Name |
cetraxate |
| Synonyms |
cetraxate hydrochloride, (trans)-isomer |
| ID |
http://purl.bioontology.org/ontology/MESH/C000665 |
| altLabel |
cetraxate hydrochloride, (trans)-isomer 4-(2-carboxyethyl)phenyl-trans-4-aminomethylcyclohexane carboxylate hydrochloride DV 1006 |
| cui |
C0055150 C0115148 C0096455 |
| Has mapping qualifier | |
| HM |
D014148/Q000031 |
| Inverse of RB |
5VPA8CPF0N 27724-96-5 |
| isa | |
| Mapped to | |
| MDA |
19720101 |
| MeSH Frequency |
62 |
| MMR |
20121105 |
| notation |
C000665 |
| PA |
D000897 |
| PI |
METHYLAMINES (72-76) *CYCLOHEXANECARBOXYLIC ACIDS (72-80) |
| prefLabel |
cetraxate |
| RR |
27724-96-5 (HCl(trans)-isomer) 34675-84-8 (cetraxate) |
| SC |
1 |
| Scope Statement |
broad spectrum peptide hydrolase inhibitor; RN given refers to (trans)-isomer; structure |
| SRC |
Adv Exp Med Biol 70:78;1976 Jpn J Pharmacol 1979;29(6):829 Arzneim Forsch 1979;29(10):1625 Arch Toxicol 1979;42(4):249 Gastroenterol Jpn 14(3):243;1979 Tokushima J Exp Med 25(3-4):151;1979 Tohoku J Exp Med 106(3):233;1972 Arch Int Pharmacodyn Ther 1979;240(2):314 |
| TERMUI |
T337469 T070757 T070756 T070755 |
| TH |
FDA SRS (2013) NLM (1972) INN (19XX) |
| tui |
T109 T121 |